Abstract
Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.
| Original language | English |
|---|---|
| Journal | American Journal of Cardiology |
| Volume | 62 |
| Issue number | 10 PART II |
| State | Published - Jan 1 1988 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. / Stack, R. S.; Califf, R. M.; Phillips, H. R.; Pryor, D. B.; Quigley, P. J.; Bauman, R. P.; Tcheng, J. E.; Greenfield, J. C.
In: American Journal of Cardiology, Vol. 62, No. 10 PART II, 01.01.1988.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone
AU - Stack, R. S.
AU - Califf, R. M.
AU - Phillips, H. R.
AU - Pryor, D. B.
AU - Quigley, P. J.
AU - Bauman, R. P.
AU - Tcheng, J. E.
AU - Greenfield, J. C.
PY - 1988/1/1
Y1 - 1988/1/1
N2 - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.
AB - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.
UR - http://www.scopus.com/inward/record.url?scp=0023681904&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023681904&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0023681904
VL - 62
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 10 PART II
ER -